After DES DiEthylStilbestrol : tracking the Harms of a Prenatal Drug Exposure

” Kari Christianson was 23 years old when she first heard of a drug called diethylstilbestrol, or DES.

It was the spring of 1972, and Dr. Arthur Herbst – who had recently published the study Adenocarcinoma of the Vagina — Association of Maternal Stilbestrol Therapy with Tumor Appearance in Young Women  suggesting that the drug, when used by pregnant women, might cause cancer in their offspring years later – was on television discussing concerns about the drug. For decades, doctors had prescribed DES to millions of healthy pregnant women, including Kari’s mother, based on unsubstantiated claims that it reduced the complications of pregnancy. “

Continue reading Kari’s story and Edward Winstead‘s post:
After DES: Tracking the Harms of a Prenatal Drug Exposure
NCI Cancer Bulletin for October 18, 2011.

More DES DiEthylStilbestrol Resources

• DES studies on cancers and screening.
• DES studies on epigenetics and transgenerational effects.
• DES studies on fertility and pregnancy.
• DES studies on gender identity and psychological health.
• DES studies on in-utero exposure to DES and side-effects.
• DES studies on the genital tract.
• Papers on DES lawsuits.
• DES videos and posts tagged DES, the DES-exposed, DES victims.